AXT Inc
NASDAQ:AXTI

Watchlist Manager
AXT Inc Logo
AXT Inc
NASDAQ:AXTI
Watchlist
Price: 11.58 USD -4.3% Market Closed
Market Cap: 539.9m USD

AXT Inc
Investor Relations

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. The company is headquartered in Fremont, California and currently employs 1,008 full-time employees. The company has two product lines: specialty material substrates and raw materials integral to these substrates. Its compound substrates combine indium with phosphorous (InP) or gallium with arsenic (GaAs). Its single element substrates are made from germanium (Ge). Its InP substrates are used in broadband and fiber optic applications, 5G infrastructure and data center connectivity. Its semi-conducting GaAs substrates are used to create opto-electronic products, including high brightness light emitting diodes (HBLEDs), liquid crystal display (LCD) televisions, and are also used for automotive panels, display and lighting applications. Its Ge substrates are used in applications, such as solar cells for space and terrestrial photovoltaic applications. Its two raw material companies sell purified gallium and pyrolytic boron nitride (pBN) crucibles.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 30, 2025
AI Summary
Q3 2025

Revenue Surge: Q3 revenue jumped to $28 million, up 56% sequentially and 18% year-over-year, driven mainly by strong indium phosphide demand.

Gross Margin Recovery: Gross margin improved significantly to 22.3%, rebounding from 8.0% last quarter, though still slightly below last year’s 24.0%.

Record Backlog: Indium phosphide order backlog reached over $49 million, the highest in company history, fueled by AI and data center demand.

Profitability Progress: Net loss shrank to $1.9 million from $7.0 million in Q2, and guidance suggests further improvement in Q4.

Export Permits Are Critical: Export permit approvals remain the biggest growth constraint; most of Q4 guidance depends on permit timing.

Q4 Guidance: Revenue expected in the $27–$30 million range; gross margin and profitability progress hinge on further efficiency gains and permit approvals.

Key Financials
Revenue
$28.0 million
Gross Margin
22.3%
Operating Expenses
$7.3 million
Operating Loss
$1.1 million loss
Net Loss
$1.9 million loss
Cash and Cash Equivalents
$31.2 million
Indium Phosphide Revenue
$13.1 million
Indium Phosphide Backlog
$49 million
Gallium Arsenide Revenue
$7.5 million
Germanium Substrates Revenue
$640,000
Raw Material Joint Venture Revenue
$6.7 million
Net Inventory
$77.7 million
Earnings Call Recording
Other Earnings Calls

Management

Dr. Morris S. Young Ph.D.
Co-Founder, CEO & Chairman
No Bio Available
Mr. Gary L. Fischer
CFO, VP & Corporate Secretary
No Bio Available
Dr. Wei Gao
Chief Technical Officer
No Bio Available

Contacts

Address
CALIFORNIA
Fremont
4281 Technology Dr
Contacts
+15104384734.0
www.axt.com